Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Keystone, Edward [1 ]
Landewe, Robert
van Vollenhoven, Ronald [2 ]
Combe, Bernard [3 ]
Strand, Vibeke [4 ]
Mease, Phillip [5 ,6 ]
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree [7 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Karolinska Inst, Stockholm, Sweden
[3] Hop Lapeyronie, F-34295 Montpellier, France
[4] Stanford Univ, Portola Valley, VA USA
[5] Swedish Med Ctr, Seattle, WA USA
[6] Univ Washington, Sch Med, Seattle, WA USA
[7] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：1455 / 1456
页数：2
相关论文
共 50 条
  • [21] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [22] Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Paiva da Silva Lima, Gabriel
    Cheng, Sunfa
    Mikol, Daniel D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (05) : 1716 - 1725
  • [23] Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study
    Saito, Takuya
    Hyodo, Yohei
    Sakaguchi, Reiko
    Nakamura, Hiroshi
    Ishigooka, Jun
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (01) : 24 - 35
  • [24] Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial
    Wernicke, Joachim F.
    Raskin, Joel
    Rosen, Amy
    Pritchett, Yili L.
    D'Souza, Deborah N.
    Iyengar, Smriti
    Knopp, Kelly
    Le, Trong K.
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2006, 67 (05): : 283 - 304
  • [25] Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer's Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Takase, Takao
    Ohbayashi, Toshio
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (03) : 232 - 239
  • [26] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL COMBINATION AND MONOTHERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
    Strand, V
    Purcaru, O.
    Van Vollenhoven, R.
    Choy, E.
    Fleischmann, R.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A451 - A452
  • [27] Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy On Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
    Strand, Vibeke
    Purcaru, Oana
    van Vollenhoven, Ronald F.
    Choy, Ernest
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S567 - S567
  • [28] Efficacy of long-term (104-week) treatment with apremilast in patients with psoriatic arthritis: Results from a phase III, randomized, controlled trial and open-label extension
    Edwards, Christopher
    Blanco, Francisco
    Crowley, Jeffrey
    Hu, Chia Chi
    Shah, Kamal
    Birbara, Charles
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [29] Long Term Tolerability and Efficacy of a 4-week-administration of Certolizumab pegol as Monotherapy and Combination Therapie in rheumatoid Arthritis-5-Year-Data of an open Extension Study
    Alten, R.
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 111 - 111
  • [30] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    [J]. CEPHALALGIA, 2020, 40 : 60 - 61
12345